Literature DB >> 2359910

Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features.

S Fidalgo1, F Vázquez, M C Mendoza, F Pérez, F J Méndez.   

Abstract

Staphylococcus epidermidis was established as the causal agent of true bacteremia on the basis of microbiologic, epidemiologic, clinical, and prognostic data on 65 episodes of S. epidermidis bacteremia (SEB) recorded in the Hospital Covadonga of Oviedo, Spain, during 1982-1986. All isolates were susceptible in vitro to vancomycin, mercury, silver, cadmium, and malachite green, and 95.2% of isolates were susceptible to cephalothin; a dominant biotype, four resistotypes (ion-dye resistance patterns), and four antibiotypes (antibiotic resistance patterns) were found. A high percentage of isolates (76.7%) produced slime, and several potentially toxic exoproteins were detected in various and generally lower proportions. The main clinical features of SEB were high frequency in male patients greater than 40 years of age, fever, leukocytosis, anemia, and phlebitis. Indwelling devices were the most common portal of entry. The overall death rate was 36.9%. Underlying disease, hemodynamic status, predisposing factors, and treatment were statistically significant parameters in relation to mortality.

Entities:  

Mesh:

Year:  1990        PMID: 2359910     DOI: 10.1093/clinids/12.3.520

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  27 in total

1.  Characteristics of Pseudomonas aeruginosa strains causing septicemia in a Spanish hospital 1981-1990.

Authors:  F Vázquez; M C Mendoza; M H Villar; A Vindel; F J Méndez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

2.  Blood proteins do not promote adherence of coagulase-negative staphylococci to biomaterials.

Authors:  E Muller; S Takeda; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

3.  Positive blood cultures for coagulase-negative staphylococci in neonates: does highly selective vancomycin usage affect outcome?

Authors:  Y Matrai-Kovalskis; D Greenberg; E S Shinwell; D Fraser; R Dagan
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

4.  Glyceraldehyde-3-phosphate dehydrogenase-encoding gene as a useful taxonomic tool for Staphylococcus spp.

Authors:  J Yugueros; A Temprano; B Berzal; M Sánchez; C Hernanz; J M Luengo; G Naharro
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence, hydrophobicity, and toxin production in vitro.

Authors:  C Molnàr; Z Hevessy; F Rozgonyi; C G Gemmell
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

6.  Rapid identification and typing of Staphylococcus aureus by PCR-restriction fragment length polymorphism analysis of the aroA gene.

Authors:  J Y Marcos; A C Soriano; M S Salazar; C H Moral; S S Ramos; M S Smeltzer; G N Carrasco
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Evaluation of Staf-Sistem 18-R for identification of staphylococcal clinical isolates to the species level.

Authors:  R Piccolomini; G Catamo; C Picciani; D D'Antonio
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

8.  High-throughput molecular identification of Staphylococcus spp. isolated from a clean room facility in an environmental monitoring program.

Authors:  Norhan S Sheraba; Aymen S Yassin; Magdy A Amin
Journal:  BMC Res Notes       Date:  2010-11-04

9.  Clinical significance of Staphylococcus warneri bacteremia.

Authors:  U Kamath; C Singer; H D Isenberg
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

Review 10.  Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9.

Authors:  K W Jauch; W Schregel; Z Stanga; S C Bischoff; P Brass; W Hartl; S Muehlebach; E Pscheidl; P Thul; O Volk
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.